<DOC>
	<DOCNO>NCT02363192</DOCNO>
	<brief_summary>Of 5.2 million people asthma UK , approximately one every 40 severe asthma need maximum available treatment advise national asthma guideline ( know 'British Thoracic Society / Scottish Intercollegiate Guidelines Network British Guideline Management Asthma ' ) . Despite , asthma still inadequately controlled half patient class 'difficult asthma ' . There maybe potential improvement care health patient well use medicine great input pharmacist , research need . The aim study measure effect six month coordinate information advice medicine hospital community pharmacist asthma control patient difficult asthma . The patient study ( 52 total ) recruit adult patient attend specialist difficult asthma clinic hospital . Patients randomly choose either appointment specialist pharmacist ( intervention group ) , usual medical care ( control group ) . Usual care involve see Consultant Specialist Registrar ( doctor ) clinic . Patients intervention group receive ) assessment education asthma , review inhaler technique , hospital Advanced Clinical Pharmacist ii ) also refer medicine use review usual community pharmacist ( chemist ) , take place 1-2 month hospital clinic appointment . The Advanced Clinical Pharmacist work closely Consultant . Results measure use method develop expert asthma test previous research . Asthma control measure use Juniper 's Asthma Control Questionnaire . Other measurement cover quality life , use medication , use healthcare resource , inhaler technique .</brief_summary>
	<brief_title>Effectiveness Pharmacist Interventions Difficult Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>Clinical diagnosis asthma Fulfil criterion difficult asthma ( define persistent symptom and/or frequent exacerbation despite treatment step 4 step 5 British TYhoracic Society / SIGN asthma guideline 2011 ) Adult patient age 18 70 year Able speak , read write English All patient must receive regular medication Community Pharmacy least 3 month prior baseline visit Their community pharmacy must register Leeds Primary Care Trust ( PCT ) undertake target Medicines Use Reviews ( tMURs ) . Failure meet inclusion criterion Patient responsible administer medication Patient unlikely available 6month followup period Failure provide write informed consent Patient MUR within 12 month precede study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Pharmacy</keyword>
</DOC>